$PVSP KRTL’s CEO, Daniel Ball, brings years of r
Post# of 53479
(Total Views: 181)
Posted On: 07/06/2022 11:54:37 AM
$PVSP KRTL’s CEO, Daniel Ball, brings years of relevant experience in cannabis and hemp, managing Oregon hemp farms, extraction and launching a testing lab and obtaining ISO 17025 accreditation through A2LA, the gold standard in environmental testing labs across the nation. He built his professional career on years of experience in the US Army where he, as a Signals Intelligence Analyst, quickly rose through the ranks and eventually, as a non-commissioned officer for a counter terrorism unit, managed deployment of over $250 million of ground and airborne assets in various global conflict zones.
"It's very rare to have such tremendous alignment and synergy between experts with the depth of knowledge and passion this team exhibits. Everyone is committed to the highest product standards, with success metrics that prioritize the positive impact and benefit to the end user - often those dealing with chronic or recurring physical or mental pain, pain that isn't easily or effectively managed through conventional medicine but has a chance for better efficacy through complementary alternative medicine. KRTL's mission aligns perfectly with this values-based posture and we're excited to be working alongside Pervasip for this very important and very timely endeavor. There's an opportunity to elevate the trajectory of the cannabinoid and terpenoid wellness market with the introduction of highly calibrated dosing and formulation methodology alongside peer-reviewed studies and due diligence, and this team is well equipped to make that happen, " KRTL’s CEO stated.
https://www.barrons.com/articles/targeting-th...rview_news
"It's very rare to have such tremendous alignment and synergy between experts with the depth of knowledge and passion this team exhibits. Everyone is committed to the highest product standards, with success metrics that prioritize the positive impact and benefit to the end user - often those dealing with chronic or recurring physical or mental pain, pain that isn't easily or effectively managed through conventional medicine but has a chance for better efficacy through complementary alternative medicine. KRTL's mission aligns perfectly with this values-based posture and we're excited to be working alongside Pervasip for this very important and very timely endeavor. There's an opportunity to elevate the trajectory of the cannabinoid and terpenoid wellness market with the introduction of highly calibrated dosing and formulation methodology alongside peer-reviewed studies and due diligence, and this team is well equipped to make that happen, " KRTL’s CEO stated.
https://www.barrons.com/articles/targeting-th...rview_news
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼